Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Antônio Mateus Gomes PereiraGraduate Program in Biotechnology, Northeast Network of Biotechnology (RENORBIO), State University of Ceará, Campus Itaperi, Fortaleza 60714-903, Brazil.
Benise Ferreira da SilvaGraduate Program in Biotechnology, Northeast Network of Biotechnology (RENORBIO), State University of Ceará, Campus Itaperi, Fortaleza 60714-903, Brazil.
Ingrid Maria Frota AraujoCenter of Bioprospection and Experimentation Molecular Applied (NUBEM), University Center INTA-UNINTA, Sobral 62050-100, Brazil.
Francisco Kauê Carvalho AguiarCenter of Bioprospection and Experimentation Molecular Applied (NUBEM), University Center INTA-UNINTA, Sobral 62050-100, Brazil.
Paulo Adenes Teixeira CoelhoCenter of Bioprospection and Experimentation Molecular Applied (NUBEM), University Center INTA-UNINTA, Sobral 62050-100, Brazil.ORCID 0000-0001-8566-5201
Renata Albuquerque CostaCenter of Bioprospection and Experimentation Molecular Applied (NUBEM), University Center INTA-UNINTA, Sobral 62050-100, Brazil.
Marcia Machado MarinhoCenter for Exact Sciences and Technology, Vale do Acaraú University, Sobral 62040-370, Brazil.
Emmanuel Silva MarinhoPostgraduate Program in Natural Sciences, Ceará State University, Fortaleza 60714-903, Brazil.ORCID 0000-0002-4774-8775
João Victor Serra NunesAnalytical Centre, Department of Physics, Federal University of Ceará, Fortaleza 60020-181, Brazil.
Victor Alves CarneiroCenter of Bioprospection and Experimentation Molecular Applied (NUBEM), University Center INTA-UNINTA, Sobral 62050-100, Brazil.ORCID 0000-0003-0116-0957
Hélcio Silva Dos SantosGraduate Program in Biotechnology, Northeast Network of Biotechnology (RENORBIO), State University of Ceará, Campus Itaperi, Fortaleza 60714-903, Brazil.ORCID 0000-0001-5527-164X
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Antibacterial and Antibiofilm Activities of Hydralazine, an Antihypertensive Drug: In Vitro and In Silico Approaches. · full record | OpenQuestion